|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
General
Trends and Clinical Characteristics of Next-Generation Sequencing–Based Genetic Panel Tests: An Analysis of Korean Nationwide Claims Data
Mi Jang, Hae Yong Pak, Ja Yoon Heo, Hyunsun Lim, Yoon-La Choi, Hyo Sup Shim, Eun Kyung Kim
Cancer Res Treat.
2024;56(1):27-36. Published online September 7, 2023 DOI:
https://doi.org/10.4143/crt.2023.844
Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies
Hye-Young Min, Ho-Young Lee
Cancer Res Treat.
2023;55(3):720-736. Published online March 22, 2023 DOI:
https://doi.org/10.4143/crt.2023.468
Web of Science 3
Crossref 5
Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice
Sahdeo Prasad, Amit K. Tyagi, Bharat B. Aggarwal
Cancer Res Treat.
2014;46(1):2-18. Published online January 15, 2014 DOI:
https://doi.org/10.4143/crt.2014.46.1.2
Web of Science 719
Crossref 646
HIF-1α: a Valid Therapeutic Target for Tumor Therapy
Soon-Sun Hong, Hyunseung Lee, Kyu-Won Kim
Cancer Res Treat.
2004;36(6):343-353. Published online December 31, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.6.343
Crossref 71
Risk Factors in
Anticancer
Chemotherapy Induced Thrombocytopenia Requiring Platelet Transfusion
Jong Hwa Lee, Jee Sook Hahn, Queh Park, Yun Woong Ko
J Korean Cancer Assoc.
2000;32(6):1093-1099.
TGFbeta1 Effect on Survival of
Anticancer
Drug - resistant L1210 Sublines
Sung Yong Kim, Kyung Sub Lee, Jae Ryong Kim, Jeong Hee Kim
J Korean Cancer Assoc.
1998;30(5):1005-1013.
Augmentaion of Cytotoxicity of
Anticancer
Drugs with Biological Response Modifiers against Human Leukemia Cell Lines
Yun Young Lee, Eui Gun Chun, Jun Young Kil, Ill Kuk Yoon, Kwan Hee Yu, Byung Zun Ahn, Sam Yong Kim
J Korean Cancer Assoc.
1994;26(2):274-285.
An Experimental Study on In Vitro Chemosensitivity Tests Using Human Cancer Cell Lines
Dae Hyun Yang, Jin Pok Kim
J Korean Cancer Assoc.
1989;21(2):376-406.
Precision Oncology Clinical Trials: A Systematic Review of Phase II Clinical Trials with Biomarker-Driven, Adaptive Design
Hyerim Ha, Hee Yeon Lee, Jee Hyun Kim, Do Yeun Kim, Ho Jung An, SeungJin Bae, Hye-sung Park, Jin Hyoung Kang
Received February 5, 2024 Accepted April 29, 2025 Published online May 7, 2024
DOI:
https://doi.org/10.4143/crt.2024.128
[Accepted]
Therapeutic Effect of Anti-Inflammatory Tripeptide Cream in Hand-Foot Syndrome/Skin Reaction Related to
Anticancer
Drugs: a Randomized, Double-Blind, Placebo-Controlled Pilot Trial
Yaewon Yang, Jang-Hee Hahn, Min Seo Kim, Minkwan Jo, Yong-Pyo Lee, Hongsik Kim, Hee Kyung Kim, Jihyun Kwon, Ki Hyeong Lee, Hye Sook Han
Received January 22, 2024 Accepted June 4, 2024 Published online June 7, 2024
DOI:
https://doi.org/10.4143/crt.2024.080
[Accepted]
1
Journal Impact Factor 4.6
> Browse Articles > Search
